Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
11.57
-0.33 (-2.77%)
At close: Nov 13, 2026, 4:00 PM EST
11.45
-0.12 (-1.04%)
After-hours: Nov 13, 2026, 7:30 PM EST
Certara Revenue
Certara had revenue of $94.90M in the quarter ending September 30, 2026, with 4.42% growth. This brings the company's total for the last twelve months to $398.74M, up 2.34% year-over-year. In the year 2025, Certara had annual revenue of $418.84M with 8.75% growth. That makes Certara the 12,221st largest company in the world by revenue and 2,396th in the United States.
Revenue (ttm)
$398.74M
Revenue Growth
+2.34%
P/S Ratio
4.15
Revenue / Employee
$270,152
Employees
1,576
Market Cap
1.76B
Revenue by Geography
- Americas 291.60M 69.6%
- EMEA 92.63M 22.1%
- Asia Pacific 34.61M 8.3%
Fiscal year ended Dec 31, 2025 See the full Certara breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 418.84M | 33.69M | 8.75% |
| Dec 31, 2024 | 385.15M | 30.81M | 8.70% |
| Dec 31, 2023 | 354.34M | 18.69M | 5.57% |
| Dec 31, 2022 | 335.64M | 49.54M | 17.32% |
| Dec 31, 2021 | 286.10M | 42.57M | 17.48% |
| Dec 31, 2020 | 243.53M | 35.02M | 16.79% |
| Dec 31, 2019 | 208.51M | 44.79M | 27.36% |
| Dec 31, 2018 | 163.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.47B |
| Privia Health Group | 2.43B |
| Waystar Holding | 1.26B |
| Omnicell | 1.24B |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| Omada Health | 333.04M |
| HealthStream | 327.95M |
CERT News
- 9 days ago - Certara price target raised to $13 from $10 at UBS - TheFly
- 9 days ago - Certara price target raised to $11.50 from $9 at Morgan Stanley - TheFly
- 9 days ago - Certara price target raised to $11 from $7 at Baird - TheFly
- 10 days ago - Certara price target raised to $12 from $9 at Barclays - TheFly
- 10 days ago - Certara price target raised to $12 from $8 at BMO Capital - TheFly
- 10 days ago - Certara price target raised to $13 from $11 at Leerink - TheFly
- 10 days ago - Certara narrows FY26 adjusted EPS view to 31c-34c from 31c-36c - TheFly
- 10 days ago - Certara reports Q3 adjusted EPS 9c, consensus 9c - TheFly